Literature DB >> 17374992

SUMO is growing senescent.

Oliver Bischof1, Anne Dejean.   

Abstract

Cellular senescence is an irreversible cell cycle arrest that curbs unrestrained, aberrant proliferation of mammalian cells and is now recognized as a prominent tumor suppressive mechanism. We have shown recently that the E3 SUMO ligase PIASy actively contributes to execution of the senescence program, thus, providing the first evidence for a direct role of SUMO modification in this process. Here, we discuss some of the implications for this novel connection and future directions to study in more detail the importance of the SUMO pathway in senescence and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374992     DOI: 10.4161/cc.6.6.4021

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

Review 1.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

2.  Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H.

Authors:  Elena Kudryashova; Irina Kramerova; Melissa J Spencer
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

3.  The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.

Authors:  Guillaume Dalmasso; Antony Cougnoux; Julien Delmas; Arlette Darfeuille-Michaud; Richard Bonnet
Journal:  Gut Microbes       Date:  2014

4.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Authors:  Lisa Ivanschitz; Yuki Takahashi; Florence Jollivet; Olivier Ayrault; Morgane Le Bras; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

5.  Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.

Authors:  Kristin E Yates; Gregory A Korbel; Michael Shtutman; Igor B Roninson; Daniel DiMaio
Journal:  Aging Cell       Date:  2008-07-24       Impact factor: 9.304

6.  Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription.

Authors:  Bhavana Chhunchha; Nigar Fatma; Eri Kubo; Dhirendra P Singh
Journal:  FEBS J       Date:  2014-07-01       Impact factor: 5.542

Review 7.  SUMOylation in brain ischemia: Patterns, targets, and translational implications.

Authors:  Joshua D Bernstock; Wei Yang; Daniel G Ye; Yuntian Shen; Stefano Pluchino; Yang-Ja Lee; John M Hallenbeck; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-17       Impact factor: 6.200

8.  Silencing nuclear pore protein Tpr elicits a senescent-like phenotype in cancer cells.

Authors:  Brigitte David-Watine
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

9.  Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?

Authors:  Frederick A Dick
Journal:  Cell Div       Date:  2007-09-13       Impact factor: 5.130

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.